Frequency of common hematological manifestations determined in newly diagnosed HIV infected patients

Paper Details

Research Paper 01/09/2017
Views (219) Download (5)

Frequency of common hematological manifestations determined in newly diagnosed HIV infected patients

Yaseen Khan, Humaira Chauhan, Hashmat Ullah, Eiman Sumayyah, Sahib Zada, Wasim Sajjad
Int. J. Biosci.11( 3), 31-40, September 2017.
Certificate: IJB 2017 [Generate Certificate]


Globally the phenomenon of Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) is noticed as pandemic, which affects almost all countries around the globe. Presently in Asia, about 4.9 million population are infected with HIV. It attacks the immune system of human body. Generally, the immune system generates several infection counter cells called T-cell lymphocytes. After infecting the immune system, within months to years, all the T-cell lymphocytes get destroy. Current study was aimed to determine the frequency of common hematological manifestations in newly diagnosed HIV infected patients. In this study, total of 271 patients were observed by using prevalence of neutropenia 2.29%, 95% confidence interval and 2% margin error using WHO sample size calculator. Moreover, non-probability consecutive sampling was used to collect samples. In this study, the mean age was 32 ± 3.51 years. 62%percent patients were male and 38% patients were female. Hematological manifestations were analyzed as 80% patients had anemia, 38% patients had total leucocyte count < 4000/µL, 20% patients had absolute lymphocyte count < 800/µL, 5% patients had absolute neutrophil count < 1000 /µL while 15% patients had total platelet count <150,000. Our study concludes that the most common hematological manifestations was anemia 80% followed by total leucocyte count < 4000/µL (38%), absolute lymphocyte count < 800/µL (20%), total platelet count <150,000 (15%) and absolute neutrophil count < 1000 /µL (5%).


Addis Z, Yitaye G, Tachebele B. 2014. Prevalence of Some Hematological Abnormalities among HIV Positive Patients on Their First Visit to a Tertiary Health Institution in Ethiopia; A Cross Sectional Study. IBRR 2(6), 270-278,

Akinbami A, Oshinaike O, Adeyemo T, Adediran A, Dosunmu O, Dada M, Durojaiye I, Adebola A, Vincent O. 2010. Hematologic Abnormalities in Treatment-Naïve HIV Patients. Lagos, Nigeria. Infectious Diseases Research and Treatment 3, 45-49.

Alaei K, Alaei A, Mansoori D.2002. Thrombocytopenia in HIV-infected patients, Islamic Republic of Iran. Eastern Mediterranean Health Journal 8, 758-764.

Boxer LA. 2012. How to approach neutropenia.  ” ASH Education Program Book 2012.1 (2012)174-182.

Calenda V, Chermann JC. 1992. The effects of HIV on hematopoiesis. European Journal of Haematology 48, 181–186.

Choi SY, Kim I, Kim NJ, Lee SA, Choi Yam. 2011. Hematological Manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean Journal of Haematology 46(4), 253-57.

Denue BA, Gashau W, Bello HS, Kida IM, Bakki B, Ajayi B. 2013. Relation between some haematological abnormalities, degree of immunosuppression and viral load in treatment-naïve HIV-infected patients. Eastern Mediterranean Health Journal 19,362-368.

Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R.2009. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Hematology 9(1), 5.

Fazal M, Fazal J, Shah Z, Hashmat UK, Muhammad A, Sahib Z, Tanweer K, Wasim S. 2017. Common bacteria and their antibiotic sensitivity among patients with acquired immunodeficiency syndrome presenting with acute diarrhea. International Journal of Biosciences 10(4), 212-221.

Ferede G, Wondimeneh Y. 2013. Prevalence and related factors of anemia in HAART-naïve HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematology 13, 8.

Ibeh BO, Omodamiro OD, Ibeh U, Habu JB. 2013. Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria. Journal of biomedical science 20(1), 73.

Imtiaz P. 2014. To study the hematological parameters as predictors of morbidity in patients with HIV infection. Global Journal of Medicine and Public Health. 3(1), 2277-9604.

Jam S, Ramezani A, Sabzvari D, Moradmand-Badie B, Seyedalinaghi S, Jabbari H, Fattahi F, Mohraz M. 2009. A cross-sectional study of anemia in human immunodeficiency virus-infected patients in Iran. Archives of Iranian Medicine12(2),145-150.

Jam S, Ramezani A, Sabzvari D, Moradmand-Badie B, Seyedalinaghi S, Jabbari H, Fattahi F, Mohraz M. 2009. A cross-sectional study of anemia in human immunodeficiency virus-infected patients in Iran. Archivesof Iranian Medicine12, 145-150.

Mathews SE, Srivastava D, Bala Yadav R, Sharma A. 2013. Association of hematological profile of Human Immunodeficiency Virus positive patients with clinicoimmunologic stages of the disease. Journal of laboratory physicians 5, 34-37.

Munyazesa E, Emile I, Mutimura E, Hoover DR, Shi Q, McGinn AP, Musiime S, Muhairwe F, Rutagengwa A, Dusingize JC, Anastos K. 2012. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: A cross sectional study. BMJ Open 2(6).

Ogba OM, Abia-Bassay LN, Epoke J, Mandor BI, Akpotuzol J, Iwatt G, Ibanga I. 2013. Hematological Profile of HIV Infected patients with opportunistic Respiratory mycosis in relation to Immune Status- A Hospital Based Cohort from Calabar, Nigeria. Tropical Medicine Surgery 1(122), 2.

Owiredu WKBA, Quaye L, Amidu N, Addai-Mensah O. 2011. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. African Health Sciences 1, 2-15.

Prendushi-Frasheri X, Shpata V, Como AHN, Pilaca A, Kraja D. 2014.Haematological abnormalities in febrile HIV-Infected patients and factors related to them. International Journal of health Science Research 4(3), 38-45.

Shen Y, Wang Z, Lu H, Wang J, Chen J, Liu L, Zhang R, Zheng Y. 2013. Prevalence of Anemia among Adults with Newly Diagnosed HIV/AIDS in China. PLoS ONE 8(9), e73807.

Wanjari A, Acharya S, Singh AP. 2013. A study of hematological profile in HIV/AIDS. International Journal of Health Science Research 3(5), 60-75.

Wondimeneh Y, Muluye D, Ferede G. 2014. Prevalence and associated factors of thrombocytopenia among HAART naïve HIV positive patients at Gondar university hospital, northwest Ethiopia. BMC Research Notes. 7, 5.

World Health Organization. 2005. Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS case definitions for Surveillance. WHO; WHO/HIV/2005.02. Available:

Zon LI, Arkin C, Groopman JE. 1987. Haematologic manifestations of the Human Immune Deficiency Virus (HIV). British Journal of Haematology 66, 251–256.